Back
QuidelOrtho 10K Form
Sell
49
QDEL
QuidelOrtho
Last Price:
40.96
Seasonality Move:
7.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | QDEL/QuidelOrtho Quarterly |
2023-11-02 | 10Q | QDEL/QuidelOrtho Quarterly |
2023-08-09 | 10Q | QDEL/QuidelOrtho Quarterly |
2023-05-04 | 10Q | QDEL/QuidelOrtho Quarterly |
2022-11-04 | 10Q | QDEL/QuidelOrtho Quarterly |
2022-08-05 | 10Q | QDEL/QuidelOrtho Quarterly |
Receive QDEL News And Ratings
See the #1 stock for the next 7 days that we like better than QDEL
QDEL Financial Statistics
Sales & Book Value
Annual Sales: | $3B |
---|---|
Cash Flow: | $71.4M |
Price / Cash Flow: | 0 |
Annual Sales: | $47.40 |
Price / Book: | 0.87 |
Profitability
EPS (TTM): | -27.90000 |
---|---|
Net Income (TTM): | $-1.87B |
Gross Margin: | $1.49B |
Return on Equity: | -47.52% |
Return on Assets: | -25.02% |
QuidelOrtho Earnings Forecast
Key QuidelOrtho Financial Ratios
- The Gross Profit Margin over the past 40 years for QDEL is 49.85%.
- The Selling, General & Administrative Expenses for QDEL have been equal to 25.46% of Gross Profit Margin.
- The Research & Development expenses have been 8.23% of Revenue.
- The Interest Expense is -1,771.29% of Operating Income.
- The Net Earning history of QDEL is -0.34% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 20 years.
QuidelOrtho Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | QDEL |
CUSIP: | 74838J |
Website: | quidelortho.com |
Debt
Debt-to-Equity Ratio: | 0.8 |
---|---|
Current Ratio: | 1.38 |
Quick Ratio: | 0.64 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 16.73 |
QDEL Technical Analysis vs Fundamental Analysis
Sell
49
QuidelOrtho (QDEL)
is a Sell
Is QuidelOrtho a Buy or a Sell?
-
QuidelOrtho stock is rated a Sell
The current QuidelOrtho [QDEL] share price is $41.16. The Score for QDEL is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.